Alnylam Pharmaceuticals | ALNY - 税前利润

金融业

USD

USD 5.13B

现金及等价物

USD 1.71B

USD 211.12M

USD 4.22B

USD 1.35B

USD 1.28B

USD 137.59M

USD 145.22M

2.23K

EPS每股收益

USD 1.99

股本和储备

USD 1.08B

USD 825.01M

债务利息支出

USD 69.29M

USD 26.63M

USD 2.48B

USD 37.3B

USD 205.99M

USD 898.54M

USD 137.59M

普通股股本

USD 133.44M

80.04

USD 221.65M

USD 1.17B

销售和管理费用

USD 282.51M

USD 200.15M

贸易债权人

USD 126.63M

应收帐款人

USD 883.96M

	税前利润	更改		日
Acadia Pharmaceuticals	USD 3.98M		22.34M	2026-03
Agios Pharmaceuticals	USD -99.11M		9.94M	2026-03
Alnylam Pharmaceuticals	USD 221.65M		60.52M	2026-03
Amgen	USD 1.51B		2.41B	2025-12
Arrowhead Research	USD 28.27M		7.85M	2025-12
BioCryst Pharmaceuticals	USD 248.02M		235.89M	2025-12
BioMarin Pharmaceutical	USD 141.2M		168.36M	2026-03
Incyte	USD 343.6M		46.34M	2026-03
Ionis Pharmaceuticals	USD -93M		135M	2026-03
Moderna	USD -799M		612M	2025-12
Neurocrine Biosciences	USD 246.8M		7.4M	2026-03
Novartis	USD 5.17B		637M	2025-09
PTC Therapeutics	USD -2.46M		136.62M	2026-03
Regeneron Pharmaceuticals	USD 1.04B		719.6M	2025-12
Sangamo BioSciences	USD -36.05M		12.94M	2024-06
Sanofi	EUR -1.16B		6.23B	2025-12
Sarepta Therapeutics	USD 343.17M		750.85M	2026-03
Takeda	JPY -52.48B		186.34B	2026-03
Tectonic Therapeutic	USD -18.97M		63K	2025-12
Ultragenyx Pharmaceutical	USD -184M		56M	2026-03
Vertex Pharmaceuticals	USD 1.25B		78.1M	2026-03
Xencor	USD -128.64M		124.37M	2026-03